MedDataX Logo

Clinical Trial of Traditional Chinese Diaoshi Jifa Therapy of Meniere's Disease

NCT ID: NCT01454726

Last Updated: 2012-12-24

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

27 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-01-31

Study Completion Date

2011-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The hypothesis of this study is that DiaoShi Jifa reduces the symptoms, such as dizziness in patients with Meniere's disease.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Created by Dr. Diao, DiaoShi Jifa is a well-known traditional Chinese Medicine approach to treat dizziness in patients with chronic diseases. The investigators designed this randomized clinical trial to examine whether Diaoshi Jifa significantly decreases dizziness in patients with Meniere's disease. There are 2 arms in this trial: One arm is DiaoShi Jifa plus conventional Western medical treatment, another is conventional Western medical treatment only. The dizziness handicap inventory (DHI) will be used to evaluate the treatment effect.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Meniere's Disease

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Dizziness Meniere's disease Diaoshi Jifa therapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

experimental group

receiving both Diaoshi Jifa therapy and the Western medical treatment.

Group Type EXPERIMENTAL

Diaoshi Jifa therapy plus the Western medical treatment.

Intervention Type OTHER

Diaoshi Jifa treatment

control group

receiving the Western medical treatment alone.

Group Type OTHER

drug

Intervention Type OTHER

the Western medical treatment alone.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Diaoshi Jifa therapy plus the Western medical treatment.

Diaoshi Jifa treatment

Intervention Type OTHER

drug

the Western medical treatment alone.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Western medical treatment: Ginkgo 20 ml qd iv, Merision 6mg tid po Western medical treatment: Ginkgo 20 ml qd iv, Merision 6mg tid po

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Clinical diagnosis of probable Meniere's disease
2. Must be able to receive manual treatment
3. Dizziness Patients receiving other treatment longer than 5 days before entering the study.

Exclusion Criteria

1. Patients with critical illness of internal medicine and surgery
2. Patients with spinal disease or other conditions that cannot receive manual treatment.
Minimum Eligible Age

20 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Beijing Hospital of Traditional Chinese Medicine

OTHER

Sponsor Role collaborator

Beijing Administration of Traditional Chinese Medicine Bureau

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jianping Jia

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jianping Jia, MD

Role: PRINCIPAL_INVESTIGATOR

Beijing Xuan Wu Hosipital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Xuan Wu Hosipital

Beijing, Beijing Municipality, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

JJT2010-22

Identifier Type: -

Identifier Source: org_study_id